ME-143

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameME-143
Drug Alias NameNV-143ME-143
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionQuinone reductase 1 inhibitors
TargetsQuinone reductase 1
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesKazia Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMei Pharma Inc
Active IndicationsN/A
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A